Thus FOXM1 is considered a promising target for therapeutic intervention in cancer [8], and its inhibitors, siomycin A and cell-penetrating ARF [26–44] peptide, induce cancer cell apoptosis [14, 15]. The gene discussed is CDKN2A; the disease is cancer.